Apellis
Apellis is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of debilitating diseases.
Business Model:
Revenue: $113M
Employees: 201-500
Industries / Tags:
Detailed Apellis Information
Geographic Data
Address: 100 5th Avenue
City: Waltham
State: MA
Zip: 02451
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$0
Raised Total:$169M
Social
Metrics
1,418,585Website Global Rank
19,095Website Monthly Traffic
Twitter Followers
Description
Apellis is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of debilitating diseases.
Contact Phone:
+16179775700
Contact Email:
Apellis went public on 11/9/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/9/2017
IPO Valuation:
$689M
Ticker Symbol:
APLS
IPO Price:
$14/share
Amount Raised:
$150M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 11/2014 | Potentia Pharmaceuticals |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
